DFJ Mercury Backs Swift Biosciences

Houston-based venture capital firm DFJ Mercury is the lead investor in a developer of molecular biology reagents. According to Michigan-based Swift Biosciences, DFJ led the firm's $3M, Series A funding. A number of individual, Michigan investors also participated in the funding. As part of the funding, Daniel Watkins of DFJ Mercury joins the company's board. Swift said its products are used to exaime disease-related genes, helping its users to analyze their samples faster, at higher volume, and at a lower price-per-sample. More information »